Cardiological Society of India and SATS launched initiative for increasing awareness about Sudden Cardiac Death

October 10, 2022
  • Total of One crore Indians to be targeted through a digital campaign and physical kiosks for raising awareness
  • The public service initiative will be supported by Sun Pharma, the No. 1 pharmaceutical company in India

 India

healthysoch

New Delhi, October 10, 2022:

The Cardiological Society of India (CSI), the largest organization of Indian Cardiologists with over 5000 members, in association with SATS (Skills Academic Training and Simulation), a critical care society accredited by American Heart Association announced the launch of an initiative to increase awareness towards the imminent danger of Sudden Cardiac Death (SCD) and teach basic principles of Cardio-Pulmonary Resuscitation (CPR).

A total of One crore Indians will be targeted through a digital campaign and physical kiosks in educational institutions, shopping malls, housing societies, police stations, post offices etc. as well as virtual web-based modules. Over the next three months, CSI will be imparting “Hands on CPR Training” under ‘CALS Initiative (CPR As a Life Skill Initiative) to 10,000 people from four metro cities – Kolkata, Mumbai, Chennai and Delhi.

This initiative will be supported by Sun Pharma, the No. 1 pharmaceutical company in India. For the past two years, Sun Pharma has been running a campaign under the banner, “Making India Heartstrong” to build awareness among patients on cardiovascular risk factors.

 Disease burden in India

The annual incidence of Sudden Cardiac Death is around 53 cases per one lakh population, and roughly accounts for 5.6 percent of total deaths in India. The fact that economically productive younger people are predominantly victims of SCD is also a matter of grave concern.

 The main reason for SCD is an underlying myocardial infarction or heart attack. In people suffering from heart attack, SCD accounts for 50 percent of deaths in the hospitalized period and in the subsequent follow-up period. Half of these deaths tend to occur in the immediate month following the heart attack, and the remainder within a year of the initial heart attack.

 healthysoch

Stay informed with the latest news from HealthySoch. Sign up today for exclusive insights and updates!

We promise we never spam!

Leave a Reply

Your email address will not be published.

Columnists

HealthySoch

Don't Miss

Centre Prohibits Exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the COVID situation in the country improves

Centre takes Various Steps to ensure easy access of Remdesivir

Wonderla Holidays honors ‘COVID Angels’

Hyderabad, July 14, 2021: Wonderla Amusement Park, Hyderabad is inviting